Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-10 08:19 am Purchase | 2023-08-09 | 13G | Apogee Therapeutics, Inc. APGE | FMR LLC | 4,447,901 12.094% | 4,447,901 (New Position) | Filing History |
| 2023-07-28 4:15 pm Purchase | 2023-07-18 | 13D | Apogee Therapeutics, Inc. APGE | Venrock Healthcare Capital Partners III, L.P. | 3,887,478 9.990% | 3,887,478 (New Position) | Filing History |
| 2023-07-24 4:05 pm Purchase | 2023-07-14 | 13G | Apogee Therapeutics, Inc. APGE | Deep Track Capital, LP | 3,023,456 8.870% | 3,023,456 (New Position) | Filing History |
| 2023-07-21 4:31 pm Purchase | 2023-07-13 | 13D | Apogee Therapeutics, Inc. APGE | Fairmount Funds Management LLC | 3,906,202 9.990% | 3,906,202 (New Position) | Filing History |